VANC Bolsters Hema-Fer Market Presence with Amazon Canada Store Launch and Advertising Approvals Pharmaceutical Investing
BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera Pharmaceutical Investing
AtriCure and Baheal Group Establish Partnership and China Distribution Agreement Pharmaceutical Investing
Verastem Oncology and Yakult Honsha Sign Exclusive License Agreement for the Development and Commercialization of Duvelisib in Japan Pharmaceutical Investing
Chugai’s HEMLIBRA Receives Priority Review Status from U.S. FDA for Hemophilia A Without Inhibitors Pharmaceutical Investing
FDA Grants Priority Review to Genentech’s HEMLIBRA (emicizumab-kxwh) for People with Hemophilia A without Factor VIII Inhibitors Genetics Investing
Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations Pharmaceutical Investing
LYNPARZA (olaparib) in Combination with Abiraterone Delayed Disease Progression in Metastatic Castration-Resistant Prostate Cancer Pharmaceutical Investing
Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
